CoChat

Bioavailability of Iron Supplement Formulations by Bariatric Surgery Type: A Pilot Study (P23-013-19)

Open access

The DOI matches its Crossref record.

Abstract

Our previous research demonstrated that ferrous sulfate, the gold standard iron supplement treats iron deficiency in bariatric surgery patients but wasn’t well tolerated. We also found that the bioavailability of iron supplements, assessed by a serum iron absorption test, predicts treatment response. The objective of the current study is to determine whether bariatric surgery type (gastric bypass [GB] and sleeve gastrectomy [SG]) or iron formulation type (inorganic ferrous sulfate versus and an organic, slow-release form of iron, called AspironTM) predicts iron supplement bioavailability. Iron-deficient GB and SG females, ages 18–65 years, who had surgery at least 6 months previously, participated in an 8-hour iron absorption test. Participants were considered iron deficient if two of the following values were abnormal: serum transferrin receptor greater than 2012 mcg/L, ferritin below 30 mcg/L, total iron binding capacity above 370 mcg/dL, and a serum transferrin receptor: ferritin ratio greater than 500. Participants received a low-iron breakfast with a 65 mg iron supplement. We assessed serum iron every 30 minutes for 8 hours following the supplementation using a calorimetric assay (South Bend Medical Foundation, South Bend, IN). We report our preliminary findings to date; the study is ongoing. Out of the 10 participants, 8 had GB and 2 had SG. Six of the GB patients and both SG patients received AspironTM, and two of the GB patients received ferrous sulfate. In GB participants, following ferrous sulfate, serum iron increased 80.5 ± 6.4 mcg/dL compared to baseline, whereas following AspironTM, serum iron increased 6.7 ± 4.6 mcg/dL compared to baseline (P = 0.000). Compared to the GB group, serum iron increased 58.5 ± 57.3 mcg/dL in the SG group following AspironTM supplementation (P = 0.037). Our preliminary findings suggest that AspironTM is not as bioavailable as ferrous sulfate in GB patients. AspironTM may be better absorbed in SG patients, indicating that it could be an effective treatment to reverse iron deficiency in the SG population. Cura Global Health Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cdn/nzz043.p23-013-19

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Still being checked.

Cited by

See all 2

Metadata

Authors
Snell-Sparapany, H., Choi, J., Rosen, A., Reddy, M., & Gletsu-Miller, N.
Affiliations
  • Purdue University West Lafayette (US)
  • Indiana University School of Medicine (US)
  • Iowa State University (US)
Venue
Current Developments in Nutrition
Publisher
Elsevier BV
Published
2019-06
Volume
3
Pages
nzz043.P23-013-19
ISSN
2475-2991 (ISSN-L)
OpenAlex
W2953209619
Cited by
2
References
0
Citations by year
2023: 1 · 2021: 1
FWCI
0.18
Type
journal article
Language
en
Open access
Licence
Locations
  • Current Developments in Nutrition (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
Keywords
iron bioavailability, iron deficiency, bariatric surgery, gastric bypass, sleeve gastrectomy, ferrous sulfate, iron supplementation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bioavailability of Iron Supplement Formulations by Bariatric Surgery Type: A Pilot Study (P23-013-19). https://app.cochat.ai/papers/10.1093/cdn/nzz043.p23-013-19
The paper
Snell-Sparapany, H., Choi, J., Rosen, A., Reddy, M., & Gletsu-Miller, N. (2019). Bioavailability of Iron Supplement Formulations by Bariatric Surgery Type: A Pilot Study (P23-013-19). Current Developments in Nutrition. https://doi.org/10.1093/cdn/nzz043.p23-013-19

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.